ResearchMoz

Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2010 - 2017

Transparency Market Research
Published Date » 2013-04-23
No. Of Pages » 115
 
 
   
 The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the increased demand for food in developing countries has spurred the growth of the bioagriculture market. Bioseeds are expected to show exponential growth as compared to conventional seeds over the forecast period. 
   
 This report on the biotechnology market analyzes and estimates the global revenue generated by the biotechnology industry over the forecast period i.e. 2012 to 2017. The scope of the report considers biotechnology to be divided into four primary segments namely biopharmacy, bioservices, bioagriculture and bioindustrial. In terms of technology, the biotechnology...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Value Chain Analysis
3.3 Market Drivers
3.3.1 Regulatory Support
3.3.2 Increasing Food Demand 
3.3.3 Limited Availability of Non-Renewable Natural Resources
3.4 Market Restraints
3.4.1 Ethical Issues Associated with Clinical Trials
3.4.2 Long Research and Development Lead Time
3.5 Market Opportunities
3.5.1 Emergence of Biosimilars
3.5.2 Biotechnology in Medical Sciences
3.6 Porters Five Force Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat from Substitutes
3.6.5 Degree of Competition
3.7 Biotechnology: Company Market Share Analysis
3.8 Biotechnology: Market Attractiveness Analysis
3.8.1 Biotechnology Market, by Application: Attractiveness Analysis
3.8.2 Biotechnology Market, by Technology: Attractiveness Analysis

Chapter 4 Global Biotechnology Market, by Application
4.1 Global Biotechnology Market: Application Overview
4.1.1 Global Biotechnology Market Revenue Share, by Application, 2010 and 2017
4.2 Biotechnology Market, by Application, 2010 - 2017
4.2.1 Biopharmacy
4.2.1.1 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
4.2.2 Bioservices
4.2.2.1 Global Bioservices Market, 2011 – 2017 (USD Billion)
4.2.3 Bioagriculture
4.2.3.1 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
4.2.4 Bioindustrial
4.2.4.1 Global Bioindustrial Market, 2011 – 2017 (USD Billion)

Chapter 5 Global Biotechnology Market, by Technology
5.1 Global Biotechnology Market Overview, by Technology
5.1.1 Global Biotechnology Market Revenue Share, by Technology, 2010 And 2017
5.2 Fermentation Technology
5.2.1 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
5.3 Tissue Engineering And Regeneration Technology
5.3.1 Global Tissue Engineering and Regeneration Technology Market, 2010 – 2017 (USD Billion)
5.4 Polymerase Chain Reaction (PCR) Technology
5.4.1 Global PCR Technology Market, 2010 – 2017 (USD Billion)
5.5 Nanobiotechnology
5.5.1 Global Nanobiotechnology Market, 2010 – 2017 (USDBillion)
5.6 Chromatography
5.6.1 Global Chromatography Market, 2010 – 2017 (USD Billion)
5.7 Dna Sequencing Technology
5.7.1 Global DNA Sequencing Technology Market, 2010 – 2017 (USD Billion)
5.8 Cell Based Assay
5.8.1 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
5.9 Others (Enzyme Technology, Finger Printing, Etc.)
5.9.1 Global Other Technologies Market, 2010 – 2017 (USD Billion)

Chapter 6 Global Biotechnology Market, by Geography
6.1 Global Biotechnology Market Overview, by Geography
6.1.1 Global Biotechnology Market Revenue Share,by Geography, 2011 and 2017
6.2 North America
6.2.1 North America Market for Biotechnology, 2010 – 2017, (USD Billion)
6.2.2 North America Market Demand For Biotechnology, By Application, 2010 – 2017, (USD Billion)
6.2.2.1 Demand for Biopharmacy in North America, 2010 – 2017, (USD Billion)
6.2.2.2 Demand for Bioservices in North America, 2010 – 2017, (USD Billion)
6.2.2.3 Demand for Bioagriculture in North America, 2010 – 2017, (USD Billion)
6.2.2.4 Demand for Bioindustrial Products in North America, 2010 – 2017, (USD Billion)
6.3 Europe
6.3.1 Europe Market for Biotechnology, 2010 – 2017, (USD Billion)
6.3.2 Europe Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.3.2.1 Demandfor Biopharmacyin Europe, 2010 – 2017, (USD Billion)
6.3.2.2 Demand for Bioservices in Europe, 2010 – 2017, (USD Billion)
6.3.2.3 Demand for Bioagriculture in Europe, 2010 – 2017, (USD Billion)
6.3.2.4 Demand for Bioindustrial Products in Europe, 2010 – 2017, (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Market for Biotechnology, 2010 – 2017, (USD Billion)
6.4.2 Asia Pacific Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.4.2.1 Demand for Biopharmacy in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.2 Demand For Bioservices in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.3 Demand For Bioagriculture in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.4 Demand For Bioindustrial Products in Asia Pacific, 2010 – 2017, (USD Billion)
6.5 Rest Of World
6.5.1 Rest of World Market for Biotechnology, 2010 – 2017, (USD Billion)
6.5.2 Rest Of World (Row) Market Demand for Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.5.2.1 Demandfor Biopharmacy in Row, 2010 – 2017, (USDBillion)
6.5.2.2 Demand for Bioservices in Row, 2010 – 2017, (USD Billion)
6.5.2.3 Demand for Bioagriculture in Row, 2010 – 2017, (USD Billion)
6.5.2.4 Demand for Bioindustrial Products in Row, 2010 – 2017, (USD Billion)

Chapter 7 Company Profile
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.1.4 Swot Analysis
7.1.5 Recent Developments
7.2 Amgen Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.2.4 Swot Analysis
7.2.5 Recent Developments
7.3 Glaxosmithkline
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.3.4 Swot Analysis
7.3.5 Recent Developments
7.4 Johnson And Johnson
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Business Strategy.
7.4.4 Swot Analysis
7.4.5 Recent Developments
7.5 Merck
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Business Strategy
7.5.4 Swot Analysis
7.5.5 Recent Developments
7.6 Novartis
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Business Strategy
7.6.4 Swot Analysis
7.6.5 Recent Developments
7.7 Novo Nordisk
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Swot Analysis
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Pfizer (Wyeth)
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Business Strategies.
7.8.4 Swot Analysis
7.8.5 Recent Developments
7.9 Roche
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Business Strategies
7.9.4 Swot Analysis
7.9.5 Recent Developments
7.10 Sanofi - Aventis
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Swot Analysis
7.10.5 Recent Developments
7.11 Lonza Group Ltd.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Business Strategy
7.11.4 Swot Analysis
7.11.5 Recent Developments
7.12 Biogen Idec Inc
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Business Strategy
7.12.4 Swot Analysis
7.12.5 Recent Developments
7.13 Astra Zeneca
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Business Strategy
7.13.4 Swot Analysis
7.13.5 Recent Developments
7.14 Genentech
7.14.1 Company Overview
7.14.2 Financial Overview
7.14.3 Business Strategies
7.14.4 Swot Analysis
7.14.5 Recent Developments
7.15 Genzyme
7.15.1 Company Overview
7.15.2 Financial Overview
7.15.3 Swot Analysis
7.15.4 Recent Developments
7.16 Gilead Sciences
7.16.1 Company Overview
7.16.2 Financial Overview
7.16.3 Swot Analysis
7.16.4 Business Strategies
7.16.5 Recent Developments
7.17 Celgene
7.17.1 Company Overview
7.17.2 Financial Overview
7.17.3 Business Strategy
7.17.4 Swot Analysis
7.17.5 Recent Developments

List of Tables


Table 1 Biotechnology Market: Global Snapshot
Table 2 Drivers For Biotechnology Market: Impact Analysis
Table 3 Restraints For Biotechnology Market : Impact Analysis

List of Figures


Fig. 1 Global Biotechnology Market, 2010 – 2017, (USD Billion)
Fig. 1 Biotechnology Industry: Value Chain Analysis
Fig. 2 World Population Growth, Billion, 2006 - 2012
Fig. 3 Bioseeds Vs. Conventional Seeds Market Demand, USD Million, 2006 - 2011
Fig. 4 Global Crude Oil Price Trend Estimate And Forecast, 2009 – 2018 (USD/Barrel)
Fig. 5 World Biofuel Production, Billion Liters, 2009 - 2018
Fig. 6 Region Split Of Victims Of Lax Clinical Trials, 2011
Fig. 7 Stages Involved In Drug Approval
Fig. 8 Porters Five Forces Analysis
Fig. 9 Biotechnology : Company Market Share, 2011
Fig. 10 Biotechnology Market, By Application: Attractiveness Analysis 2011
Fig. 11 Biotechnology Market, By Application: Attractiveness Analysis, 2011
Fig. 12 Global Biotechnology Market Revenue Share, By Application, 2011 And 2017
Fig. 13 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
Fig. 14 Global Bioservices Market, 2011 – 2017 (USD Billion)
Fig. 15 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
Fig. 16 Global Bioindustrial Market, 2011 – 2017 (USD Billion)
Fig. 17 Global Biotechnology Market Revenue Share, By Technology, 2011 And 2017
Fig. 18 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
Fig. 19 Global Tissue Engineering And Regeneration Technology Market, 2010 – 2017 (USD Billion)
Fig. 20 Global PCR Technology Market, 2010 – 2017 (USD Billion)
Fig. 21 Global Nanobiotechnology Market, 2010 – 2017 (USD Billion)
Fig. 22 Global Chromatography Market, 2010 – 2017 (USD Billion)
Fig. 23 Global Dna Sequencing Technology Market, 2010 – 2017 (USD Billion)
Fig. 24 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
Fig. 25 Global Other Technologies Market, 2010 – 2017 (USD Billion)
Fig. 26 Global Biotechnology Market Revenue Share, By Geography, 2011 And 2017
Fig. 27 North America Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 28 Demand For Biopharmacy In North America, 2010 – 2017, (USD Billion)
Fig. 29 Demand For Bioservices In North America, 2010 – 2017, (USD Billion)
Fig. 30 Demand For Bioagriculture In North America, 2010 – 2017, (USD Billion)
Fig. 31 Demand For Bioindustrial Products In North America, 2010 – 2017, (USD Billion)
Fig. 32 Europe Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 33 Demand For Biopharmacy In Europe, 2010 – 2017, (USD Billion)
Fig. 34 Demand For Bioservices In Europe, 2010 – 2017, (USD Billion)
Fig. 35 Demand For Bioagriculture In Europe, 2010 – 2017, (USD Billion)
Fig. 36 Demand For Bioindustrial Products In Europe, 2010 – 2017, (USD Billion)
Fig. 37 Asia Pacific Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 38 Demand For Biopharmacy In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 39 Demand For Bioservices In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 40 Demand For Bioagriculture In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 41 Demand For Bioindustrial Products In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 42 Rest Of World Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 43 Demand For Biopharmacy In Row, 2010 – 2017, (USD Billion)
Fig. 44 Demand For Bioservices In Row, 2010 – 2017, (USD Billion)
Fig. 45 Demand For Bioagriculture In Row, 2010 – 2017, (USD Billion)
Fig. 46 Demand For Bioindustrial Products In Row, 2010 – 2017, (USD Billion)

Upcoming Reports:

Greece: frozen potatoes market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the frozen potatoes market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the frozen potatoes market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview...
Advanced Structural Carbon Products Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Advanced structural carbon products are materials which are manufactured from different allotropes of carbon such as amorphous carbon and graphite. Certain products such as carbon-reinforced carbon composites, monolithic structural graphite, carbon fibers, and carbon foams are produced in the industry. These products are used in an extensive range of applications such as industrial, automotives, aerospace & defense, and energy.  Several growth factors such as technological advancement in enhancing property-structural connection of the advanced carbon materials and...
Critical Limb Ischemia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Critical limb ischemia (CLI) is a kind of peripheral arterial disease (PAD) in which chronic inflammation associated with atherosclerosis (progressive thickening of arteries lining) causes reduced blood flow to the extremities (legs, feet and hands), leading to severe pain and ulcers or sore. Some major risk factors for critical limb ischemia comprise aging (people aged 60 or over are at high risk of developing this diseased condition), diabetes, obesity, high cholesterol level, sedentary lifestyle, smoking and high blood pressure. Critical limb ischemia is associated with most common...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

New Drug Shows Early Promise against Heart Attacks and Strokes
Sep 1, 2014  
Sanofi and Regeneron Pharmaceuticals have been working on a new experimental drug that aims to lower cholesterol. Early tests have shown that the drug cuts down risks of heart attacks and strokes in clinical trials by half. The test report says that the results are not conclusive as the analysis was performed retrospectively. The study does provide the positive result that...
New Materials Creation Strategy
Sep 1, 2014  
Scientists always aim at theorizing about new compounds and materials; however after Researchers have made use of X-ray scattering in a process known as molecular beam epitaxy (MBE) to understand atom behavior as a kind of material called as layered oxides were getting formed. For computational predictions of new materials, the available observations were utilized for providing insights on...
Western Africa economies hit by Ebola travel ban
Aug 28, 2014  
With over 1,400 people dead due to the fatal Ebola outbreak in African countries, travel services have either banned or limited operations to the western region, severely hitting economies of the area. Budgetary resources are being utilized rapidly and economic growth has dropped by 4% as international projects and trips have been cancelled. Transport companies have cut off the region...
Fonterra Ties Up With Beingmate to Tap into China’s Baby Food Market
Aug 28, 2014  
Fonterra Co-Operative Group Ltd. will partner with Beingmate Group Co, China’s biggest infant formula manufacturer to increase its reach in the Chinese market. The New Zealand-based company makes this move with the intent to grab a bigger market share in China after it suffered many setbacks in the food-safety scandal last year.   This partnership will also help Beingmate...
Chinas Leading Asset-Management Company Aims for IPO
Aug 28, 2014  
China’s biggest asset-management company plans to go public by the end of 2015. Chinese authorities are constantly ramping up their interests towards introducing mixed ownership to state-owned huge companies and call for more private capital investments into the economy. According to the news report, China Huarong Asset Management Co., Ltd. will collaborate with eight investors...